SEC Form 4 · accession 0001140361-15-028643
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Gould
Director
Period of report
Jul 22, 2015
Accepted (ET)
Jul 24, 2015 · 9:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2015 | A | 5,266 | $0.00 | A | 27,025 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $15.95 | Jul 22, 2015 | A | 6,022 | A | Jul 22, 2016 | Jul 22, 2022 | Common Stock | 6,022 | 6,022 | D |
Explanation of responses
- F1The acquisition of 5,266 shares of common stock represents 5,266 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 07/22/2016.
- F2Options for 33 1/3% of the shares are each exercisable on 07/22/2016, 07/22/2017 and 07/22/2018, respectively.